Topic · page 34 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 1,321–1,360 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

Arthritis Res Ther4 Apr 2023
Stratified distribution of Th17 and Treg cells in patients with multi-stage rheumatoid arthritis
Cross-sectional study
Clin Exp Rheumatol4 Apr 2023
Elevated serum soluble CD27 levels are associated with both disease activity and humoral immune activity in patients with rheumatoid arthritis
Cross-sectional study
JAMA Netw Open3 Apr 2023
Management of Rheumatoid Arthritis With a Digital Health Application: A Multicenter, Pragmatic Randomized Clinical Trial
Randomized controlled trial
Arthritis Rheumatol2 Apr 2023
Efficacy and Safety of ABBV ‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with Moderate‐to‐Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double‐Blind , Active‐Controlled Proof‐of‐Concept Phase IIa Trial
Randomized controlled trial
Lancet RheumatolApril 2023
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
Randomized controlled trial
Arthritis Rheumatol29 Mar 2023
Prediction of Erosive Disease Development by Antimitochondrial Antibodies in Rheumatoid Arthritis
Cross-sectional study
Scand J Rheumatol28 Mar 2023
Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis
Diagnostic or prognostic study
RMD Open28 Mar 2023
Pilot study of tocilizumab monotherapy for active chronic periaortitis
Research article
Arthritis Care Res (Hoboken)28 Mar 2023
Socioeconomic, Disease‐Related, and Personal Factors Associated With Participation in Remote Follow‐Up in Rheumatoid Arthritis: A Cross‐Sectional Study
Cross-sectional study
Lancet Rheumatol27 Mar 2023
Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study
Cohort study
Arthritis Res Ther25 Mar 2023
Optical spectral transmission to assess glucocorticoid therapy response in patients with arthritis: a longitudinal follow-up comparison with joint ultrasound
Diagnostic or prognostic study
Rheumatology (Oxford)24 Mar 2023
Characteristics of patients with difficult-to-treat rheumatoid arthritis in a French single-centre hospital
Cross-sectional study
Rheumatology (Oxford)21 Mar 2023
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA
Cohort study
Arthritis Res Ther20 Mar 2023
Radiographic airway abnormalities in untreated early rheumatoid arthritis are associated with peripheral neutrophil activation
Cross-sectional study
Arthritis Res Ther17 Mar 2023
Clinical characteristics of rheumatoid arthritis patients with interstitial lung disease: baseline data of a single-center prospective cohort
Cohort study
Ann Rheum Dis17 Mar 2023
Identification of two tofacitinib subpopulations with different relative risk versus TNF inhibitors: an analysis of the open label, randomised controlled study ORAL Surveillance
Secondary analysis
RMD Open16 Mar 2023
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
Cohort study
Rheumatology (Oxford)15 Mar 2023
Mortality estimates and excess mortality in rheumatoid arthritis
Cohort study
J Rheumatol15 Mar 2023
Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure Definitions
Cohort study
Ann Rheum Dis14 Mar 2023
Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance
Mechanistic study
Semin Arthritis Rheum11 Mar 2023
A scoping review of shared care models for rheumatoid arthritis with patient-initiated follow-up
Research article
Semin Arthritis Rheum10 Mar 2023
Prevalence and risk factors of falls in adults with rheumatoid arthritis: A systematic review and meta-analysis
Meta-analysis
Semin Arthritis Rheum9 Mar 2023
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis
Meta-analysis
RMD Open8 Mar 2023
Difficult-to-treat rheumatoid arthritis (D2T RA): clinical issues at early stages of disease
Cohort study
Arthritis Res Ther8 Mar 2023
Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations
Cross-sectional study
Arthritis Care Res (Hoboken)7 Mar 2023
Effectiveness and Persistence in SB4‐ and Reference Etanercept–Treated Rheumatoid Arthritis Patients in Ordinary Clinical Practice in Norway
Cohort study
Arthritis Res Ther4 Mar 2023
The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999–2018
Cross-sectional study
Arthritis Care Res (Hoboken)4 Mar 2023
Uptake and Spending on Biosimilar Infliximab and Etanercept After New Start and Switching Policies in Canada: An Interrupted Time Series Analysis
Research article
Ann Rheum Dis3 Mar 2023
Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study
Cohort study
Arthritis Res Ther2 Mar 2023
Factors associated with the composition of the gut microbiome in patients with established rheumatoid arthritis and its value for predicting treatment responses
Cross-sectional study
RMD Open2 Mar 2023
Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study
Guideline or statement
Arthritis Care Res (Hoboken)2 Mar 2023
Rheumatoid Arthritis Disease Activity and Hospitalized Infection in a Large US Registry
Cohort study
JAMA Netw Open1 Mar 2023
Incidence of Interstitial Lung Disease in Patients With Rheumatoid Arthritis Treated With Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs
Cohort study
RMD Open28 Feb 2023
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers
Cohort study
Arthritis Res Ther27 Feb 2023
Radiographic damage in early rheumatoid arthritis is associated with increased disability but not with pain—a 5-year follow-up study
Cohort study
Arthritis Rheumatol26 Feb 2023
Diversity and Clonality of T Cell Receptor Repertoire and Antigen Specificities in Small Joints of Early Rheumatoid Arthritis
Mechanistic study
Rheumatology (Oxford)24 Feb 2023
Characteristics of patients initiating treatment with baricitinib and outcomes at follow-up: analysis of BSRBR-RA Registry data
Cohort study
Rheumatology (Oxford)24 Feb 2023
The impact of health literacy: associations with disease activity and medication prescription in patients with rheumatoid arthritis
Cohort study
Clin Exp Rheumatol24 Feb 2023
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry
Cohort study
Rheumatology (Oxford)23 Feb 2023
Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application
Cohort study

All 1,564 Briefs in ExploreShowing Briefs 1,321–1,360 of 1,564, newest first